Pharmacology Drug Class Flashcards: Mechanisms, Uses & Safety Patterns

Study 126 cards on 30 common drug classes: mechanisms, qualified generic-name patterns, common uses, and major safety concepts for nursing and introductory health science.

Σχετικά με αυτήν τη δέσμη

Build a durable pharmacology map with 126 independently authored cards. Six prerequisites define drug classes, mechanisms, agonism, antagonism, inhibition, and how to treat generic-name stems as fallible clues. The remaining 120 cards cover 30 common classes through four separate retrieval directions: class → core mechanism; qualified pattern or representative generics → class; class → common use; and class → major safety concept.

The deck deliberately excludes dosing, prescribing, patient-specific guidance, administration or hold parameters, exhaustive contraindications and interactions, monitoring protocols, brand names, official questions, and clinical cases. Generic-name patterns are clues, never universal rules. Use this deck for study—not clinical decision-making.

Ordering supports learning: prerequisites come first, then five spiral blocks mix six broad topic groups. Same-class variants stay at least three unrelated cards apart, alternating mechanism, recognition, common-use, and safety recall instead of forming predictable runs.

Open Study Contributor independently authored this standalone deck from common pharmacology knowledge checked against WHO, FDA, and NIH/NCBI sources. Organization names identify sources only; no affiliation or endorsement is claimed.

Κάρτες σε αυτήν τη δέσμη

  1. Κάρτα 1

    Ερώτηση

    What is a drug class?

    Απάντηση

    A group of drugs linked by a shared mechanism, target, structure, therapeutic use, or a combination of these features.

  2. Κάρτα 2

    Ερώτηση

    What does mechanism of action mean?

    Απάντηση

    How a drug produces its effects at a molecular, cellular, or physiological target.

  3. Κάρτα 3

    Ερώτηση

    What is a receptor agonist?

    Απάντηση

    A drug that binds to a receptor and activates it to produce a response.

  4. Κάρτα 4

    Ερώτηση

    What is a receptor antagonist?

    Απάντηση

    A drug that binds to a receptor and blocks or reduces activation by an agonist.

  5. Κάρτα 5

    Ερώτηση

    What does it mean when a drug inhibits an enzyme or transporter?

    Απάντηση

    It reduces that protein's activity, changing the movement or conversion of its usual substrates.

  6. Κάρτα 6

    Ερώτηση

    How should generic-name stems be used to recognize drug classes?

    Απάντηση

    As clues, not universal rules. Confirm the actual drug because exceptions and overlapping stems exist.

  7. Κάρτα 7

    Ερώτηση

    ACE inhibitors: core mechanism?

    Απάντηση

    They inhibit angiotensin-converting enzyme, reducing angiotensin II and aldosterone while increasing bradykinin.

  8. Κάρτα 8

    Ερώτηση

    SSRIs: core mechanism?

    Απάντηση

    They inhibit the serotonin transporter, increasing serotonin signaling in the synaptic cleft.

  9. Κάρτα 9

    Ερώτηση

    Biguanides: core mechanism?

    Απάντηση

    Metformin mainly reduces hepatic glucose production and improves insulin sensitivity without directly stimulating insulin release.

  10. Κάρτα 10

    Ερώτηση

    Penicillins: core mechanism?

    Απάντηση

    Their beta-lactam ring binds penicillin-binding proteins and disrupts bacterial cell-wall synthesis.

  11. Κάρτα 11

    Ερώτηση

    Which class is often suggested by the ending -pril?

    Απάντηση

    ACE inhibitors. Examples include lisinopril and enalapril, but a name stem is only a clue.

  12. Κάρτα 12

    Ερώτηση

    Proton-pump inhibitors: core mechanism?

    Απάντηση

    They inhibit the H+/K+ ATPase proton pump in gastric parietal cells, strongly reducing acid secretion.

  13. Κάρτα 13

    Ερώτηση

    SSRIs: common uses?

    Απάντηση

    Depression and several anxiety-related disorders; the approved indications differ by agent.

  14. Κάρτα 14

    Ερώτηση

    NSAIDs: core mechanism?

    Απάντηση

    They inhibit cyclooxygenase enzymes, reducing prostaglandin synthesis.

  15. Κάρτα 15

    Ερώτηση

    Biguanides: major safety concepts?

    Απάντηση

    Gastrointestinal effects are common; vitamin B12 can fall with long use, and lactic acidosis is rare but serious.

  16. Κάρτα 16

    Ερώτηση

    Which class is often suggested by the ending -cillin?

    Απάντηση

    Penicillins, such as amoxicillin and piperacillin. The stem does not describe spectrum or resistance.

  17. Κάρτα 17

    Ερώτηση

    ACE inhibitors: common uses?

    Απάντηση

    Hypertension and selected heart-failure, post-myocardial-infarction, and kidney-protection indications.

  18. Κάρτα 18

    Ερώτηση

    Proton-pump inhibitors: major safety concepts?

    Απάντηση

    Possible concerns include hypomagnesemia and enteric infection risk. Many other long-term links are observational rather than proven causal effects.

  19. Κάρτα 19

    Ερώτηση

    Which class is often suggested by -oxetine or -opram?

    Απάντηση

    SSRIs, but not universally. Sertraline and fluvoxamine are exceptions, and some stems overlap other classes.

  20. Κάρτα 20

    Ερώτηση

    NSAIDs: common uses?

    Απάντηση

    Pain, inflammation, and fever; individual agents also have more specific uses.

  21. Κάρτα 21

    Ερώτηση

    Metformin belongs to which drug class?

    Απάντηση

    Biguanides. Metformin is the main widely used member, so there is no useful class-wide suffix rule.

  22. Κάρτα 22

    Ερώτηση

    Penicillins: major safety concepts?

    Απάντηση

    Hypersensitivity can range from rash to anaphylaxis; diarrhea and antibiotic-associated colitis are additional concerns.

  23. Κάρτα 23

    Ερώτηση

    ACE inhibitors: major safety concepts?

    Απάντηση

    Cough, hyperkalemia, kidney-function changes, angioedema, and fetal harm are major class concerns.

  24. Κάρτα 24

    Ερώτηση

    Proton-pump inhibitors: common uses?

    Απάντηση

    Acid-related disorders such as GERD, erosive esophagitis, and peptic-ulcer disease.

  25. Κάρτα 25

    Ερώτηση

    SSRIs: major safety concepts?

    Απάντηση

    Serotonin syndrome, bleeding and hyponatremia risks, sexual dysfunction, and the antidepressant suicidality warning for younger people.

  26. Κάρτα 26

    Ερώτηση

    Ibuprofen, naproxen, and ketorolac belong to which class?

    Απάντηση

    NSAIDs. The class has no single reliable generic-name suffix.

  27. Κάρτα 27

    Ερώτηση

    Biguanides: common use?

    Απάντηση

    Type 2 diabetes.

  28. Κάρτα 28

    Ερώτηση

    Penicillins: common use?

    Απάντηση

    Treatment of susceptible bacterial infections; the spectrum differs substantially among individual penicillins.

  29. Κάρτα 29

    Ερώτηση

    Which class is often suggested by the ending -prazole?

    Απάντηση

    Proton-pump inhibitors, such as omeprazole and pantoprazole. Confirm the individual drug.

  30. Κάρτα 30

    Ερώτηση

    NSAIDs: major safety concepts?

    Απάντηση

    Gastrointestinal bleeding, kidney injury, fluid retention, and cardiovascular events are key risks; FDA also warns about use from about 20 weeks of pregnancy.

  31. Κάρτα 31

    Ερώτηση

    Sulfonylureas: core mechanism?

    Απάντηση

    They close ATP-sensitive potassium channels in pancreatic beta cells, triggering insulin release even when glucose is not high.

  32. Κάρτα 32

    Ερώτηση

    H2 blockers: core mechanism?

    Απάντηση

    They competitively block histamine H2 receptors on gastric parietal cells, reducing acid secretion.

  33. Κάρτα 33

    Ερώτηση

    SNRIs: core mechanism?

    Απάντηση

    They inhibit serotonin and norepinephrine reuptake transporters, increasing both transmitters in synapses.

  34. Κάρτα 34

    Ερώτηση

    Opioid analgesics: core mechanism?

    Απάντηση

    They activate opioid receptors; many important analgesic effects and toxicities are mediated through mu receptors.

  35. Κάρτα 35

    Ερώτηση

    Glipizide, glyburide, and glimepiride belong to which class?

    Απάντηση

    Sulfonylureas. Their names offer clues, but the broad ending -ide is not class-specific.

  36. Κάρτα 36

    Ερώτηση

    ARBs: core mechanism?

    Απάντηση

    They block angiotensin II at AT1 receptors, reducing vasoconstriction and aldosterone effects.

  37. Κάρτα 37

    Ερώτηση

    H2 blockers: common uses?

    Απάντηση

    Acid-related disorders such as heartburn, GERD, and gastric or duodenal ulcers.

  38. Κάρτα 38

    Ερώτηση

    Cephalosporins: core mechanism?

    Απάντηση

    Their beta-lactam ring binds penicillin-binding proteins and disrupts bacterial cell-wall synthesis.

  39. Κάρτα 39

    Ερώτηση

    SNRIs: major safety concepts?

    Απάντηση

    Serotonin syndrome, blood-pressure increases, discontinuation symptoms, and the antidepressant suicidality warning for younger people.

  40. Κάρτα 40

    Ερώτηση

    Morphine, oxycodone, and fentanyl belong to which broad class?

    Απάντηση

    Opioid analgesics. The class has no single reliable generic-name suffix.

  41. Κάρτα 41

    Ερώτηση

    Sulfonylureas: common use?

    Απάντηση

    Type 2 diabetes when increasing pancreatic insulin release is appropriate.

  42. Κάρτα 42

    Ερώτηση

    ARBs: major safety concepts?

    Απάντηση

    Hyperkalemia, hypotension, kidney-function changes, and fetal harm are major concerns; cough is less common than with ACE inhibitors.

  43. Κάρτα 43

    Ερώτηση

    Which class is often suggested by the ending -tidine?

    Απάντηση

    H2 receptor blockers, such as famotidine and cimetidine. Confirm the individual drug.

  44. Κάρτα 44

    Ερώτηση

    Cephalosporins: common use?

    Απάντηση

    Treatment of susceptible bacterial infections; antibacterial spectrum varies widely by agent and generation.

  45. Κάρτα 45

    Ερώτηση

    Which name endings can suggest an SNRI?

    Απάντηση

    -faxine or sometimes -oxetine, but neither is decisive. The -oxetine ending also appears in some SSRIs.

  46. Κάρτα 46

    Ερώτηση

    Opioid analgesics: major safety concepts?

    Απάντηση

    Respiratory depression, sedation, constipation, tolerance, dependence, and overdose; benzodiazepines and other depressants increase danger.

  47. Κάρτα 47

    Ερώτηση

    Sulfonylureas: major safety concepts?

    Απάντηση

    Hypoglycemia and weight gain are the main class patterns, with risk differing among agents and clinical contexts.

  48. Κάρτα 48

    Ερώτηση

    ARBs: common uses?

    Απάντηση

    Hypertension and selected heart-failure and kidney-protection indications.

  49. Κάρτα 49

    Ερώτηση

    H2 blockers: major safety concepts?

    Απάντηση

    They are usually well tolerated, but confusion or other CNS effects can occur with reduced clearance; cimetidine has many interactions.

  50. Κάρτα 50

    Ερώτηση

    Which class is often suggested by cef- or ceph-?

    Απάντηση

    Cephalosporins, such as cefazolin and cephalexin. The name does not reveal the full spectrum.

  51. Κάρτα 51

    Ερώτηση

    SNRIs: common uses?

    Απάντηση

    Depression and anxiety disorders; selected agents also treat neuropathic pain or fibromyalgia.

  52. Κάρτα 52

    Ερώτηση

    Opioid analgesics: common uses?

    Απάντηση

    Analgesia for selected severe pain and perioperative settings; individual opioids also have other specific uses.

  53. Κάρτα 53

    Ερώτηση

    Which class is often suggested by the ending -sartan?

    Απάντηση

    Angiotensin II receptor blockers, or ARBs. Examples include losartan and valsartan.

  54. Κάρτα 54

    Ερώτηση

    Cephalosporins: major safety concepts?

    Απάντηση

    Hypersensitivity and antibiotic-associated diarrhea are important; penicillin cross-reactivity depends largely on similar side chains.

  55. Κάρτα 55

    Ερώτηση

    Beta2 agonists: core mechanism?

    Απάντηση

    They activate beta2 receptors, increasing cAMP and relaxing airway smooth muscle.

  56. Κάρτα 56

    Ερώτηση

    Beta blockers: core mechanism?

    Απάντηση

    They antagonize beta-adrenergic receptors; beta1 blockade can reduce heart rate, contractility, and renin release.

  57. Κάρτα 57

    Ερώτηση

    Systemic corticosteroids: core mechanism?

    Απάντηση

    They bind intracellular glucocorticoid receptors and alter gene transcription, reducing inflammatory and immune signaling.

  58. Κάρτα 58

    Ερώτηση

    Benzodiazepines: core mechanism?

    Απάντηση

    They positively modulate GABA-A receptors, increasing the frequency of chloride-channel opening when GABA is present.

  59. Κάρτα 59

    Ερώτηση

    Which class is often suggested by the ending -terol?

    Απάντηση

    Beta2 agonist bronchodilators, such as formoterol and salmeterol. Albuterol is a familiar exception.

  60. Κάρτα 60

    Ερώτηση

    Macrolides: core mechanism?

    Απάντηση

    They bind the bacterial 50S ribosomal subunit and inhibit protein synthesis.

  61. Κάρτα 61

    Ερώτηση

    Beta blockers: common uses?

    Απάντηση

    Selected cardiovascular conditions such as arrhythmias, ischemic heart disease, heart failure, and hypertension; some agents have noncardiac uses.

  62. Κάρτα 62

    Ερώτηση

    GLP-1 receptor agonists: core mechanism?

    Απάντηση

    They activate GLP-1 receptors, increasing glucose-dependent insulin release, suppressing glucagon, and slowing gastric emptying.

  63. Κάρτα 63

    Ερώτηση

    Systemic corticosteroids: major safety concepts?

    Απάντηση

    Infection, hyperglycemia, osteoporosis, and hypothalamic-pituitary-adrenal suppression; risks rise with systemic exposure and duration.

    Abstract pharmacology study cover showing an unmarked capsule and tablet encircled by six colorful receptor, channel, enzyme, and signaling motifs on a navy field.

    126 κάρτες

    Pharmacology Drug Class Flashcards: Mechanisms, Uses & Safety Patterns

    Μελετήστε αυτήν τη δέσμη δωρεάν

    Το Nibomo ανοίγει για να ξεκινήσετε τη μελέτη.

  64. Κάρτα 64

    Ερώτηση

    Which endings often suggest a benzodiazepine?

    Απάντηση

    -azepam or -azolam, as in diazepam or midazolam. Not every sedative with a similar ending belongs to this class.

  65. Κάρτα 65

    Ερώτηση

    Beta2 agonists: common use?

    Απάντηση

    Bronchodilation in asthma or COPD regimens; short- and long-acting agents play different roles.

  66. Κάρτα 66

    Ερώτηση

    Macrolides: major safety concepts?

    Απάντηση

    Gastrointestinal effects, QT prolongation, and clinically important interactions that vary by agent.

  67. Κάρτα 67

    Ερώτηση

    Which class is often suggested by the ending -olol?

    Απάντηση

    Beta blockers, such as metoprolol and propranolol. Receptor selectivity still varies by agent.

  68. Κάρτα 68

    Ερώτηση

    GLP-1 receptor agonists: common uses?

    Απάντηση

    Type 2 diabetes; selected agents are also approved for chronic weight management and cardiovascular-risk reduction.

  69. Κάρτα 69

    Ερώτηση

    Which patterns often suggest a systemic corticosteroid?

    Απάντηση

    -sone or -olone, as in prednisone or prednisolone, but these endings are not unique to the class.

  70. Κάρτα 70

    Ερώτηση

    Benzodiazepines: major safety concepts?

    Απάντηση

    Sedation, dependence and withdrawal, plus respiratory depression—especially with opioids, alcohol, or other CNS depressants.

  71. Κάρτα 71

    Ερώτηση

    Beta2 agonists: major safety concepts?

    Απάντηση

    Tremor, palpitations or tachycardia, hypokalemia, and rare paradoxical bronchospasm.

  72. Κάρτα 72

    Ερώτηση

    Macrolides: common use?

    Απάντηση

    Treatment of selected susceptible bacterial infections, including some respiratory and atypical pathogens.

  73. Κάρτα 73

    Ερώτηση

    Beta blockers: major safety concepts?

    Απάντηση

    Bradycardia and hypotension; nonselective agents can cause bronchospasm, and the class can mask adrenergic signs of hypoglycemia.

  74. Κάρτα 74

    Ερώτηση

    Which class is often suggested by -glutide?

    Απάντηση

    GLP-1 receptor agonists, such as semaglutide and liraglutide. Exenatide and lixisenatide show the pattern is not universal.

  75. Κάρτα 75

    Ερώτηση

    Systemic corticosteroids: common uses?

    Απάντηση

    Inflammatory, allergic, and autoimmune disorders, with the route and agent chosen for the condition.

  76. Κάρτα 76

    Ερώτηση

    Benzodiazepines: common uses?

    Απάντηση

    Anxiety, seizures, procedural sedation, or alcohol withdrawal, depending on the agent and setting.

  77. Κάρτα 77

    Ερώτηση

    Which class is often suggested by the ending -thromycin?

    Απάντηση

    Macrolide antibiotics, such as azithromycin and clarithromycin. Confirm the individual agent.

  78. Κάρτα 78

    Ερώτηση

    GLP-1 receptor agonists: major safety concepts?

    Απάντηση

    Gastrointestinal effects are common; gallbladder disease and pancreatitis are warnings, and some labels warn about thyroid C-cell tumors.

  79. Κάρτα 79

    Ερώτηση

    Second-generation antipsychotics: core mechanism?

    Απάντηση

    Most modulate dopamine D2 and serotonin 5-HT2A signaling, but receptor profiles vary substantially by agent.

  80. Κάρτα 80

    Ερώτηση

    Tetracyclines: core mechanism?

    Απάντηση

    They bind the bacterial 30S ribosomal subunit and inhibit protein synthesis.

  81. Κάρτα 81

    Ερώτηση

    Dihydropyridine calcium-channel blockers: core mechanism?

    Απάντηση

    They block L-type calcium channels mainly in vascular smooth muscle, causing arteriolar relaxation.

  82. Κάρτα 82

    Ερώτηση

    Inhaled antimuscarinics: core mechanism?

    Απάντηση

    They block airway muscarinic receptors, reducing vagal bronchoconstriction and promoting bronchodilation.

  83. Κάρτα 83

    Ερώτηση

    Which endings often suggest a second-generation antipsychotic?

    Απάντηση

    -apine or -idone often appear, but many members use other endings and the stems are not class-specific.

  84. Κάρτα 84

    Ερώτηση

    SGLT2 inhibitors: core mechanism?

    Απάντηση

    They inhibit renal sodium-glucose cotransporter 2, increasing urinary glucose and sodium excretion.

  85. Κάρτα 85

    Ερώτηση

    Tetracyclines: common uses?

    Απάντηση

    Selected susceptible bacterial infections and, for some agents, acne or rosacea.

  86. Κάρτα 86

    Ερώτηση

    Bisphosphonates: core mechanism?

    Απάντηση

    They bind bone mineral and inhibit osteoclast-mediated bone resorption.

  87. Κάρτα 87

    Ερώτηση

    Dihydropyridine calcium-channel blockers: major safety concepts?

    Απάντηση

    Peripheral edema, flushing, headache, dizziness, and hypotension are characteristic patterns.

  88. Κάρτα 88

    Ερώτηση

    Which class is often suggested by the ending -tropium?

    Απάντηση

    Inhaled antimuscarinic bronchodilators, such as ipratropium and tiotropium. Several class members use other endings.

  89. Κάρτα 89

    Ερώτηση

    Second-generation antipsychotics: common uses?

    Απάντηση

    Schizophrenia and selected bipolar or other psychiatric indications; approvals differ by agent.

  90. Κάρτα 90

    Ερώτηση

    SGLT2 inhibitors: major safety concepts?

    Απάντηση

    Genital infections, volume depletion, ketoacidosis, and rare necrotizing infection of the perineum.

  91. Κάρτα 91

    Ερώτηση

    Which class is often suggested by the ending -cycline?

    Απάντηση

    Tetracycline antibiotics, such as doxycycline and minocycline. Confirm the individual drug.

  92. Κάρτα 92

    Ερώτηση

    Bisphosphonates: common uses?

    Απάντηση

    Osteoporosis and selected disorders with excessive bone resorption, including Paget disease or malignancy-related bone disease.

  93. Κάρτα 93

    Ερώτηση

    Which class is often suggested by the ending -dipine?

    Απάντηση

    Dihydropyridine calcium-channel blockers, such as amlodipine and nifedipine.

  94. Κάρτα 94

    Ερώτηση

    Inhaled antimuscarinics: major safety concepts?

    Απάντηση

    Dry mouth, urinary retention, tachycardia, and eye exposure that may worsen narrow-angle glaucoma.

  95. Κάρτα 95

    Ερώτηση

    Second-generation antipsychotics: major safety concepts?

    Απάντηση

    Metabolic effects, movement disorders, QT effects, and neuroleptic malignant syndrome; labels warn about increased mortality in elderly patients with dementia-related psychosis.

  96. Κάρτα 96

    Ερώτηση

    SGLT2 inhibitors: common uses?

    Απάντηση

    Type 2 diabetes; selected agents also treat heart failure or chronic kidney disease.

  97. Κάρτα 97

    Ερώτηση

    Tetracyclines: major safety concepts?

    Απάντηση

    Gastrointestinal or esophageal irritation, photosensitivity, and effects on developing teeth and bone are key patterns.

  98. Κάρτα 98

    Ερώτηση

    Which class is often suggested by the ending -dronate?

    Απάντηση

    Bisphosphonates, such as alendronate and risedronate. Confirm the individual agent and formulation.

  99. Κάρτα 99

    Ερώτηση

    Dihydropyridine calcium-channel blockers: common uses?

    Απάντηση

    Hypertension and angina, using vascular smooth-muscle relaxation to reduce arterial tone.

  100. Κάρτα 100

    Ερώτηση

    Inhaled antimuscarinics: common use?

    Απάντηση

    Maintenance bronchodilation, especially in COPD; selected agents also serve as add-on asthma therapy.

  101. Κάρτα 101

    Ερώτηση

    Which class is often suggested by the ending -gliflozin?

    Απάντηση

    SGLT2 inhibitors, such as empagliflozin and dapagliflozin.

  102. Κάρτα 102

    Ερώτηση

    Bisphosphonates: major safety concepts?

    Απάντηση

    Upper-GI irritation with oral agents, hypocalcemia, and rare osteonecrosis of the jaw or atypical femur fracture.

  103. Κάρτα 103

    Ερώτηση

    TNF inhibitors: core mechanism?

    Απάντηση

    They neutralize tumor necrosis factor signaling, reducing downstream inflammation.

  104. Κάρτα 104

    Ερώτηση

    DPP-4 inhibitors: core mechanism?

    Απάντηση

    They inhibit DPP-4, prolonging endogenous incretin activity and increasing glucose-dependent insulin release.

  105. Κάρτα 105

    Ερώτηση

    Inhaled corticosteroids: core mechanism?

    Απάντηση

    They activate glucocorticoid receptors in airway cells, reducing inflammatory gene expression and airway inflammation.

  106. Κάρτα 106

    Ερώτηση

    Statins: core mechanism?

    Απάντηση

    They inhibit HMG-CoA reductase, reducing hepatic cholesterol synthesis and increasing hepatic LDL-receptor activity.

  107. Κάρτα 107

    Ερώτηση

    Adalimumab, infliximab, and etanercept belong to which class?

    Απάντηση

    TNF inhibitors. The class has no single specific shared suffix: -mab is broad, and etanercept ends in -cept.

  108. Κάρτα 108

    Ερώτηση

    Triptans: core mechanism?

    Απάντηση

    They activate serotonin 5-HT1B/1D receptors, reducing trigeminal signaling and causing cranial vasoconstriction.

  109. Κάρτα 109

    Ερώτηση

    DPP-4 inhibitors: common use?

    Απάντηση

    Type 2 diabetes, using enhanced endogenous incretin signaling to improve glucose-dependent insulin release.

  110. Κάρτα 110

    Ερώτηση

    Fluoroquinolones: core mechanism?

    Απάντηση

    They inhibit bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication.

  111. Κάρτα 111

    Ερώτηση

    Inhaled corticosteroids: major safety concepts?

    Απάντηση

    Oral candidiasis and dysphonia are important local effects; systemic effects become more relevant with higher exposure.

  112. Κάρτα 112

    Ερώτηση

    Which class is suggested by the ending -statin?

    Απάντηση

    HMG-CoA reductase inhibitors, or statins, such as atorvastatin and rosuvastatin.

  113. Κάρτα 113

    Ερώτηση

    TNF inhibitors: common uses?

    Απάντηση

    Selected autoimmune inflammatory diseases, including rheumatoid arthritis, inflammatory bowel disease, and psoriasis-related conditions.

  114. Κάρτα 114

    Ερώτηση

    Triptans: major safety concepts?

    Απάντηση

    Vasoconstrictive risk in coronary, cerebrovascular, or peripheral vascular disease, plus tingling, flushing, or chest pressure called triptan sensations.

  115. Κάρτα 115

    Ερώτηση

    Which class is suggested by the ending -gliptin?

    Απάντηση

    DPP-4 inhibitors, such as sitagliptin and linagliptin.

  116. Κάρτα 116

    Ερώτηση

    Fluoroquinolones: common use?

    Απάντηση

    Selected serious or resistant bacterial infections when their spectrum and risk profile fit the infection.

  117. Κάρτα 117

    Ερώτηση

    Which patterns often suggest an inhaled corticosteroid?

    Απάντηση

    -sonide or -sone often appear, as in budesonide or fluticasone, but these endings are not class-specific.

  118. Κάρτα 118

    Ερώτηση

    Statins: major safety concepts?

    Απάντηση

    Muscle symptoms and rare rhabdomyolysis or liver injury; pregnancy is a major risk context, although FDA no longer applies a blanket class contraindication.

  119. Κάρτα 119

    Ερώτηση

    TNF inhibitors: major safety concepts?

    Απάντηση

    Serious infections and reactivation of tuberculosis or hepatitis B are central concerns; other warnings vary by agent.

  120. Κάρτα 120

    Ερώτηση

    Triptans: common use?

    Απάντηση

    Acute treatment of migraine attacks; they are not general-purpose analgesics or routine migraine preventives.

  121. Κάρτα 121

    Ερώτηση

    DPP-4 inhibitors: major safety concepts?

    Απάντηση

    Severe joint pain and pancreatitis are warnings; some agents also carry a heart-failure warning.

  122. Κάρτα 122

    Ερώτηση

    Which class is suggested by the ending -floxacin?

    Απάντηση

    Fluoroquinolone antibiotics, such as ciprofloxacin and levofloxacin.

  123. Κάρτα 123

    Ερώτηση

    Inhaled corticosteroids: common use?

    Απάντηση

    Controller therapy for asthma and selected COPD regimens; they reduce inflammation rather than acting as standalone rescue bronchodilators.

  124. Κάρτα 124

    Ερώτηση

    Statins: common uses?

    Απάντηση

    Lowering LDL cholesterol and reducing atherosclerotic cardiovascular risk.

  125. Κάρτα 125

    Ερώτηση

    Which class is suggested by the ending -triptan?

    Απάντηση

    Triptan antimigraine agents, such as sumatriptan and rizatriptan.

  126. Κάρτα 126

    Ερώτηση

    Fluoroquinolones: major safety concepts?

    Απάντηση

    Potentially disabling tendon, muscle, joint, nerve, and CNS effects, plus a rare risk of aortic aneurysm or rupture in susceptible people.

Abstract pharmacology study cover showing an unmarked capsule and tablet encircled by six colorful receptor, channel, enzyme, and signaling motifs on a navy field.

126 κάρτες

Pharmacology Drug Class Flashcards: Mechanisms, Uses & Safety Patterns

Μελετήστε αυτήν τη δέσμη δωρεάν

Το Nibomo ανοίγει για να ξεκινήσετε τη μελέτη.